nodes	percent_of_prediction	percent_of_DWPC	metapath
Trilostane—ESR1—ovarian cancer	0.674	1	CbGaD
Trilostane—HSD3B1—corpus luteum—ovarian cancer	0.0564	0.264	CbGeAlD
Trilostane—HSD3B1—ovarian follicle—ovarian cancer	0.0441	0.207	CbGeAlD
Trilostane—HSD3B2—ovarian follicle—ovarian cancer	0.035	0.164	CbGeAlD
Trilostane—ESR2—ovarian follicle—ovarian cancer	0.0114	0.0534	CbGeAlD
Trilostane—ESR1—ovarian follicle—ovarian cancer	0.00781	0.0366	CbGeAlD
Trilostane—ESR2—oviduct—ovarian cancer	0.00501	0.0235	CbGeAlD
Trilostane—HSD3B1—decidua—ovarian cancer	0.0046	0.0215	CbGeAlD
Trilostane—HSD3B1—gonad—ovarian cancer	0.00405	0.019	CbGeAlD
Trilostane—HSD3B1—female reproductive system—ovarian cancer	0.00362	0.0169	CbGeAlD
Trilostane—ESR1—oviduct—ovarian cancer	0.00343	0.0161	CbGeAlD
Trilostane—HSD3B1—female gonad—ovarian cancer	0.00329	0.0154	CbGeAlD
Trilostane—HSD3B2—gonad—ovarian cancer	0.00321	0.015	CbGeAlD
Trilostane—HSD3B1—testis—ovarian cancer	0.00292	0.0137	CbGeAlD
Trilostane—HSD3B2—female reproductive system—ovarian cancer	0.00286	0.0134	CbGeAlD
Trilostane—HSD3B2—female gonad—ovarian cancer	0.00261	0.0122	CbGeAlD
Trilostane—HSD3B2—testis—ovarian cancer	0.00231	0.0108	CbGeAlD
Trilostane—HSD3B2—lymph node—ovarian cancer	0.00168	0.00785	CbGeAlD
Trilostane—ESR2—epithelium—ovarian cancer	0.00126	0.00589	CbGeAlD
Trilostane—ESR2—uterine cervix—ovarian cancer	0.00125	0.00584	CbGeAlD
Trilostane—ESR2—endometrium—ovarian cancer	0.00113	0.00529	CbGeAlD
Trilostane—ESR1—myometrium—ovarian cancer	0.0011	0.00514	CbGeAlD
Trilostane—ESR1—embryo—ovarian cancer	0.00106	0.00495	CbGeAlD
Trilostane—ESR2—gonad—ovarian cancer	0.00105	0.0049	CbGeAlD
Trilostane—ESR2—uterus—ovarian cancer	0.00104	0.00487	CbGeAlD
Trilostane—Danazol—PGR—ovarian cancer	0.000998	0.208	CrCbGaD
Trilostane—ESR2—female reproductive system—ovarian cancer	0.000935	0.00438	CbGeAlD
Trilostane—ESR1—epithelium—ovarian cancer	0.000862	0.00404	CbGeAlD
Trilostane—ESR1—uterine cervix—ovarian cancer	0.000855	0.004	CbGeAlD
Trilostane—ESR2—female gonad—ovarian cancer	0.000851	0.00398	CbGeAlD
Trilostane—ESR2—vagina—ovarian cancer	0.000845	0.00396	CbGeAlD
Trilostane—ESR1—decidua—ovarian cancer	0.000814	0.00381	CbGeAlD
Trilostane—ESR1—endometrium—ovarian cancer	0.000773	0.00362	CbGeAlD
Trilostane—ESR2—testis—ovarian cancer	0.000754	0.00353	CbGeAlD
Trilostane—ESR1—gonad—ovarian cancer	0.000717	0.00336	CbGeAlD
Trilostane—ESR1—uterus—ovarian cancer	0.000712	0.00334	CbGeAlD
Trilostane—ESR1—female reproductive system—ovarian cancer	0.00064	0.003	CbGeAlD
Trilostane—Danazol—ESR1—ovarian cancer	0.00063	0.131	CrCbGaD
Trilostane—ESR1—female gonad—ovarian cancer	0.000583	0.00273	CbGeAlD
Trilostane—ESR1—vagina—ovarian cancer	0.000579	0.00271	CbGeAlD
Trilostane—Estradiol—CYP1B1—ovarian cancer	0.00057	0.119	CrCbGaD
Trilostane—ESR2—lymph node—ovarian cancer	0.000547	0.00256	CbGeAlD
Trilostane—Progesterone—PGR—ovarian cancer	0.000517	0.108	CrCbGaD
Trilostane—ESR1—testis—ovarian cancer	0.000517	0.00242	CbGeAlD
Trilostane—Progesterone—CYP1B1—ovarian cancer	0.000483	0.101	CrCbGaD
Trilostane—Testosterone—CYP1B1—ovarian cancer	0.000457	0.0952	CrCbGaD
Trilostane—Estradiol—ESR1—ovarian cancer	0.000385	0.0802	CrCbGaD
Trilostane—ESR1—lymph node—ovarian cancer	0.000375	0.00175	CbGeAlD
Trilostane—Progesterone—ESR1—ovarian cancer	0.000327	0.068	CrCbGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.00024	0.00223	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PGR—ovarian cancer	0.000237	0.0022	CbGpPWpGaD
Trilostane—ESR1—FOXA1 transcription factor network—CDKN1B—ovarian cancer	0.000232	0.00216	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—CCND1—ovarian cancer	0.000229	0.00213	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—MMP9—ovarian cancer	0.000227	0.00211	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—MMP2—ovarian cancer	0.000226	0.0021	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.000224	0.00208	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—YAP1—ovarian cancer	0.000223	0.00207	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—GADD45A—ovarian cancer	0.000222	0.00207	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000211	0.00196	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000209	0.00194	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—TTF1—ovarian cancer	0.000207	0.00192	CbGpPWpGaD
Trilostane—ESR1—Estrogen signaling pathway—AKT1—ovarian cancer	0.000207	0.00192	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CHEK2—ovarian cancer	0.000203	0.00189	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—NRAS—ovarian cancer	0.000201	0.00187	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.0002	0.00186	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—FASN—ovarian cancer	0.000198	0.00184	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000198	0.00184	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—NR5A1—ovarian cancer	0.000197	0.00183	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—SLC5A5—ovarian cancer	0.000194	0.00181	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—PGR—ovarian cancer	0.000194	0.00181	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—BRCA1—ovarian cancer	0.00019	0.00177	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—NR5A1—ovarian cancer	0.000188	0.00175	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—SLC2A1—ovarian cancer	0.000188	0.00175	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—CXCL8—ovarian cancer	0.000188	0.00175	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000186	0.00173	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.000184	0.00171	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—MYC—ovarian cancer	0.000184	0.00171	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000184	0.00171	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—YAP1—ovarian cancer	0.000184	0.00171	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.000184	0.00171	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000182	0.00169	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—PARP1—ovarian cancer	0.000181	0.00168	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—MYC—ovarian cancer	0.000181	0.00168	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CYP1B1—ovarian cancer	0.00018	0.00167	CbGpPWpGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—ovarian cancer	0.000175	0.00163	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—CCND1—ovarian cancer	0.000175	0.00163	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—MTOR—ovarian cancer	0.000174	0.00162	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—KRAS—ovarian cancer	0.000173	0.00161	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—BRCA2—ovarian cancer	0.000172	0.0016	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.000171	0.00159	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000171	0.00159	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000168	0.00157	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000167	0.00156	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000167	0.00156	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—ovarian cancer	0.000164	0.00152	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CXCL8—ovarian cancer	0.000164	0.00152	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000164	0.00152	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—CDKN1B—ovarian cancer	0.000164	0.00152	CbGpPWpGaD
Trilostane—Estradiol—ABCB1—ovarian cancer	0.000163	0.0341	CrCbGaD
Trilostane—ESR1—Leptin signaling pathway—ERBB2—ovarian cancer	0.000163	0.00152	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—MTOR—ovarian cancer	0.000161	0.0015	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—IL2—ovarian cancer	0.00016	0.00149	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.00016	0.00149	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CDKN1B—ovarian cancer	0.00016	0.00149	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PPP2R1A—ovarian cancer	0.00016	0.00148	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—ovarian cancer	0.000159	0.00148	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000159	0.00148	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.000158	0.00147	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000158	0.00147	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000158	0.00147	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL2—ovarian cancer	0.000156	0.00145	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—CCND1—ovarian cancer	0.000156	0.00145	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000153	0.00143	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CCND1—ovarian cancer	0.000153	0.00142	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CTNNB1—ovarian cancer	0.000151	0.0014	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—FASN—ovarian cancer	0.00015	0.00139	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—TP53—ovarian cancer	0.000148	0.00138	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ABCB1—ovarian cancer	0.000148	0.00138	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—MMP9—ovarian cancer	0.000148	0.00138	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—HRAS—ovarian cancer	0.000147	0.00137	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SLC5A5—ovarian cancer	0.000147	0.00137	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—PTEN—ovarian cancer	0.000147	0.00137	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—TYMS—ovarian cancer	0.000146	0.00135	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—CCND1—ovarian cancer	0.000144	0.00134	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—MAPK3—ovarian cancer	0.000144	0.00134	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.000143	0.00133	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SLC2A1—ovarian cancer	0.000142	0.00132	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000142	0.00132	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000139	0.0013	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000139	0.00129	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000139	0.00129	CbGpPWpGaD
Trilostane—Progesterone—ABCB1—ovarian cancer	0.000139	0.0289	CrCbGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.000138	0.00128	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.000138	0.00128	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—MAPK1—ovarian cancer	0.000137	0.00128	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP1B1—ovarian cancer	0.000136	0.00127	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.000136	0.00126	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.000135	0.00126	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	0.000134	0.00125	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.000134	0.00125	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—WDR77—ovarian cancer	0.000133	0.00124	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—MYC—ovarian cancer	0.000131	0.00122	CbGpPWpGaD
Trilostane—Testosterone—ABCB1—ovarian cancer	0.000131	0.0273	CrCbGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000131	0.00122	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—AKT1—ovarian cancer	0.00013	0.00121	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—MAPK3—ovarian cancer	0.000129	0.0012	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—MYC—ovarian cancer	0.000125	0.00116	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—STAT3—ovarian cancer	0.000125	0.00116	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—IL6ST—ovarian cancer	0.000124	0.00116	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—MAPK1—ovarian cancer	0.000122	0.00114	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—EGFR—ovarian cancer	0.000122	0.00114	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—MYC—ovarian cancer	0.000122	0.00114	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PPP2R1A—ovarian cancer	0.000121	0.00113	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.00012	0.00112	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—MAPK3—ovarian cancer	0.000119	0.00111	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.000118	0.0011	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CAV1—ovarian cancer	0.000117	0.00109	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—MAPK1—ovarian cancer	0.000113	0.00105	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ABCB1—ovarian cancer	0.000112	0.00104	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—YAP1—ovarian cancer	0.000112	0.00104	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000112	0.00104	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.000112	0.00104	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	0.000111	0.00103	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—TYMS—ovarian cancer	0.00011	0.00103	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	0.000109	0.00101	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.000109	0.00101	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—YAP1—ovarian cancer	0.000107	0.000997	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PIK3CG—ovarian cancer	0.000107	0.000994	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	0.000106	0.000989	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	0.000106	0.000988	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—IL6—ovarian cancer	0.000105	0.00098	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PIK3CD—ovarian cancer	0.000105	0.000977	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—TTF1—ovarian cancer	0.000104	0.00097	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—ESR1—ovarian cancer	0.000104	0.000965	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HSD17B6—ovarian cancer	0.000102	0.000946	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—TP53—ovarian cancer	0.0001	0.000934	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	0.0001	0.000934	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	9.96e-05	0.000926	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—PGR—ovarian cancer	9.8e-05	0.000911	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL6—ovarian cancer	9.61e-05	0.000893	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—NR5A1—ovarian cancer	9.48e-05	0.000881	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PIK3CD—ovarian cancer	9.4e-05	0.000874	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PGR—ovarian cancer	9.36e-05	0.00087	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—ERBB2—ovarian cancer	9.28e-05	0.000863	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	9.23e-05	0.000858	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	9.21e-05	0.000856	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL6—ovarian cancer	9.2e-05	0.000855	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PIK3CB—ovarian cancer	9.16e-05	0.000852	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—MTOR—ovarian cancer	9.16e-05	0.000852	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—PARP1—ovarian cancer	9.11e-05	0.000847	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—HRAS—ovarian cancer	9.09e-05	0.000845	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	8.92e-05	0.00083	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CAV1—ovarian cancer	8.89e-05	0.000827	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PARP1—ovarian cancer	8.7e-05	0.000809	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—AKT1—ovarian cancer	8.68e-05	0.000807	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—DLC1—ovarian cancer	8.65e-05	0.000804	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—CDKN1B—ovarian cancer	8.6e-05	0.000799	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.5e-05	0.00079	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	8.47e-05	0.000788	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	8.25e-05	0.000767	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PIK3CB—ovarian cancer	8.19e-05	0.000761	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	8.17e-05	0.000759	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PIK3CG—ovarian cancer	8.1e-05	0.000753	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—AKT1—ovarian cancer	8.03e-05	0.000746	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	7.96e-05	0.00074	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PTEN—ovarian cancer	7.92e-05	0.000736	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	7.73e-05	0.000719	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	7.55e-05	0.000702	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.54e-05	0.000701	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	7.19e-05	0.000668	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	7.16e-05	0.000666	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PIK3CD—ovarian cancer	7.12e-05	0.000662	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PTEN—ovarian cancer	7.08e-05	0.000658	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—NRAS—ovarian cancer	7.06e-05	0.000657	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PPP2R1A—ovarian cancer	7.06e-05	0.000656	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—BCL9—ovarian cancer	7.05e-05	0.000655	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	7.02e-05	0.000653	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	6.83e-05	0.000635	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	6.77e-05	0.000629	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—MAPK3—ovarian cancer	6.76e-05	0.000629	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	6.61e-05	0.000615	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	6.59e-05	0.000613	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	6.47e-05	0.000602	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	6.47e-05	0.000601	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—MAPK1—ovarian cancer	6.44e-05	0.000598	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—EGFR—ovarian cancer	6.43e-05	0.000598	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PIK3CB—ovarian cancer	6.21e-05	0.000577	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	6.11e-05	0.000568	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—KRAS—ovarian cancer	6.08e-05	0.000565	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	5.96e-05	0.000554	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	5.63e-05	0.000524	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PIK3CA—ovarian cancer	5.58e-05	0.000519	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—DOK1—ovarian cancer	5.57e-05	0.000518	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	5.48e-05	0.00051	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	5.43e-05	0.000505	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—YAP1—ovarian cancer	5.4e-05	0.000502	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—MYC—ovarian cancer	5.4e-05	0.000502	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PTEN—ovarian cancer	5.36e-05	0.000499	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	5.36e-05	0.000498	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	5.36e-05	0.000498	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PPP1CC—ovarian cancer	5.24e-05	0.000487	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—HRAS—ovarian cancer	5.17e-05	0.00048	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	5.06e-05	0.000471	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—ESR1—ovarian cancer	5e-05	0.000465	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PIK3CA—ovarian cancer	4.99e-05	0.000464	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—IL6—ovarian cancer	4.95e-05	0.00046	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PGR—ovarian cancer	4.72e-05	0.000439	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	4.65e-05	0.000433	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	4.59e-05	0.000426	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—AKT1—ovarian cancer	4.56e-05	0.000424	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	4.5e-05	0.000418	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PARP1—ovarian cancer	4.39e-05	0.000408	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—AKT1—ovarian cancer	4.08e-05	0.000379	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HDAC6—ovarian cancer	3.97e-05	0.000369	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	3.8e-05	0.000353	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PIK3CA—ovarian cancer	3.78e-05	0.000352	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PPP2R1A—ovarian cancer	3.56e-05	0.000331	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—YAP1—ovarian cancer	3.51e-05	0.000327	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—XIAP—ovarian cancer	3.44e-05	0.00032	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SMARCA4—ovarian cancer	3.35e-05	0.000312	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—EREG—ovarian cancer	3.27e-05	0.000304	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—AKT1—ovarian cancer	3.09e-05	0.000287	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PGR—ovarian cancer	3.07e-05	0.000285	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PARP1—ovarian cancer	2.85e-05	0.000265	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—MYC—ovarian cancer	2.72e-05	0.000253	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—MAPK3—ovarian cancer	2.67e-05	0.000248	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—MYC—ovarian cancer	2.6e-05	0.000242	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PPP2R1A—ovarian cancer	2.31e-05	0.000215	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TERT—ovarian cancer	1.84e-05	0.000171	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—AKT1—ovarian cancer	1.8e-05	0.000168	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CAV1—ovarian cancer	1.7e-05	0.000158	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IL6ST—ovarian cancer	1.61e-05	0.00015	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—APC—ovarian cancer	1.55e-05	0.000144	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PIK3CG—ovarian cancer	1.55e-05	0.000144	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PIK3CD—ovarian cancer	1.36e-05	0.000127	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—MAPK3—ovarian cancer	1.35e-05	0.000125	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—MYC—ovarian cancer	1.31e-05	0.000122	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ERBB2—ovarian cancer	1.2e-05	0.000112	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MTOR—ovarian cancer	1.19e-05	0.00011	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PIK3CB—ovarian cancer	1.19e-05	0.00011	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CXCL8—ovarian cancer	1.14e-05	0.000106	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CDKN1B—ovarian cancer	1.11e-05	0.000104	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CASP3—ovarian cancer	1.09e-05	0.000101	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IL2—ovarian cancer	1.09e-05	0.000101	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCND1—ovarian cancer	1.06e-05	9.88e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CTNNB1—ovarian cancer	1.05e-05	9.78e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MMP9—ovarian cancer	1.03e-05	9.59e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PTEN—ovarian cancer	1.03e-05	9.53e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—VEGFA—ovarian cancer	9.26e-06	8.61e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—STAT3—ovarian cancer	9.17e-06	8.53e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NRAS—ovarian cancer	9.15e-06	8.51e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—AKT1—ovarian cancer	9.09e-06	8.45e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MAPK3—ovarian cancer	8.76e-06	8.15e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MYC—ovarian cancer	8.52e-06	7.92e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MAPK1—ovarian cancer	8.34e-06	7.75e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—EGFR—ovarian cancer	8.33e-06	7.75e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—KRAS—ovarian cancer	7.87e-06	7.32e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PIK3CA—ovarian cancer	7.23e-06	6.73e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TP53—ovarian cancer	7e-06	6.51e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HRAS—ovarian cancer	6.69e-06	6.22e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IL6—ovarian cancer	6.41e-06	5.96e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AKT1—ovarian cancer	5.91e-06	5.49e-05	CbGpPWpGaD
